Despite a U.S. law requiring them to publish results of clinical trials, nearly half of clinical trials for cancer drugs were unavailable three years later.
Yay Big Pharma
Despite a U.S. law requiring them to publish results of clinical trials, nearly half of clinical trials for cancer drugs were unavailable three years later.